JSI gives an award to the superior presenters in the workshop and poster session of the JSI Annual Meeting.
One / Two awardees are selected in an each category by workshop coordinators and chairpersons.
This award is supported by BioLegend and Tomy Digital Biology.
1. Hematopoiesis and Immune Environment
Program No | Name | Title |
---|---|---|
1-H-W6-19-O/P | Yusuke Amemiya (Tokyo University of Science) | Accumulation of leukemic cells to the spleen is regulated by a transcription factor Tlx1 expressed in perifollicular mesenchymal cells |
2. B cells
Program No | Name | Title |
---|---|---|
2-F-W10-19-O/P | Sarah G Leach (Osaka University) | Requirement for memory B cell activation in protection from heterologous influenza virus reinfection |
3. T cells
Program No | Name | Title |
---|---|---|
1-C-W1-16-O/P | Kosuke Miyauchi (RIKEN) | The influenza virus replication derived broad protective antibody response |
2-C-W8-6-O/P | Tomoyoshi Yamano (Kanazawa University) | A role of extracelluar vesicles in T cell development |
4. Innate lymphocytes
Program No | Name | Title |
---|---|---|
3-E-W19-5-O/P | Natsuko Otaki (Keio University) | The role of group 2 innate lymphoid cells(ILC2) in pulmonary fibrosis |
5. Dendritic cells, macrophages, granulocytes
Program No | Name | Title |
---|---|---|
3-F-W20-3-O/P | Hisashi Ueta (Dokkyo Medical University) | Novel DC targeting by allogenic T-cells for multifocal prophylactic antibody production |
3-F-W21-6-O/P | Etsuko Toda (Nippon Medical School) | A chemokine signal amplifier FROUNT regulates tumor cell-mediated macrophage activation and migration to tumor sites |
6. Allergy
Program No | Name | Title |
---|---|---|
3-D-W17-12-O/P | Kazumasa Kanemaru (University of Tsukuba) | Clec10a regulates mite-induced dermatitis |
3-D-W18-38-O/P | Hiroki Kabata (Keio University) | Targeted deletion of TSLP receptor reveals cellular mechanisms underlying acute versus chronic type 2 inflammation |
7. Cytokines and chemokines
Program No | Name | Title |
---|---|---|
1-D-W2-15-O/P | Yuki Hikichi (RIKEN) | The mechanism for regulation of type 2 cytokine production from ILC2 by Tristetraprolin. |
8. Tolerance and Immune suppression
Program No | Name | Title |
---|---|---|
1-E-W3-3-O/P | Kazuki Sato (University of Tsukuba) | DNAM-1 suppresses Foxp3 stability of regulatory T cells in a TIGIT dependent manner |
9. Virus infectionBacterial / mycofungal / parasite infection
Program No | Name | Title |
---|---|---|
3-C-W15-5-O/P | Kana Ishikawa (Kumamoto University) | Circulating extracellular vesicle miR-451a, but not human papilloma virus vaccine, plays a crucial role in an autoimmune disorder |
3-C-W16-3-O/P | Ariel Pradipta (Osaka University) | Critical role of Irgm2 in host defense mechanism against Toxoplasma gondii |
10. Innate immunity
Program No | Name | Title |
---|---|---|
1-G-W5-19-O/P | Takashi Mino (Kyoto University) | Unwinding of stem-loops by UPF1 licenses Regnase-1 to degrade inflammatory mRNAs |
2-E-W9-6-O/P | Kohei Tsujimoto (Osaka University) | Lamtor1/p18 is required for activation of inflammasome |
11. Mucosal-Skin Immunity
Program No | Name | Title |
---|---|---|
2-G-W11-15-O/P | Takuro Nii (Osaka University) | Intestinal Prevotella copri isolated from rheumatoid arthritis patients exacerbates murine models of arthritis |
3-G-W22-1-O/P | Motoyoshi Nagai (Keio University) | The impact of fasting on immune cell dynamics and mucosal immune response |
3-G-W23-13-O/P | Sonoko Takahashi (RIKEN) | Homeostatic pruning and activity of epidermal nerves are dysregulated in barrier-impaired skin during chronic itch development |
12. Autoimmune diseases
Program No | Name | Title |
---|---|---|
2-B-W7-1-O/P | Natsuko Yamakawa (National Institutes of Biomedical Innovation, Health and Nutrition) | Human TLR7 deficiency results in autoimmune conditions |
3-B-W13-21-O/P | Hachiro Konaka (Osaka University) | Inflammasome drives release of mitochondrial DNA enclosed in extracellular membrane vesicles and propagation of inflammation in Bechet disease |
3-B-W14-2-O/P | Nobuhiko Takahashi (Hokkaido University) | Survival of peripherally derived monocytes in the CNS is crucial for EAE relapse |
13. Tumor immunity
Program No | Name | Title |
---|---|---|
2-H-W12-1-O/P | Shohei Koyama (Osaka University) | Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors |
3-H-W24-7-O/P | Yuta Nakazawa (University of Tsukuba) | An inhibitory immunoreceptor CD300a suppresses tumor infiltrating Treg cells and tumor development through binding to phosphatidylserine on tumor-derived exosomes |
3-H-W25-17-O/P | Hiroyasu Aoki (Tokyo University of Science) | Antibody-mediated transient depletion of CD4+ cells enhances the remodeling of the T-cell receptor repertoire and promotes anti-tumor immune responses in cancer patients |
14. Human Immunology (Immunointervention)
Program No | Name | Title |
---|---|---|
1-F-W4-6-O/P | Ari Itoh-Nakadai (RIKEN) | Creation of HLA class I and class II Tg NOD/SCID/Il2rgKO (NSG) mice for studying interaction between human immunity and leukemia |